Address: #73 Scout Fernandez Street, Tomas Morato
Quezon City, Metro Manila
Philippines
Tel: +632 411-5860
From a modest beginning in Marikina, Philippines in 1989, Lloyd Laboratories, Inc. has become a major player in the Pharmaceutical Manufacturing Industry and is considered as a leading, professionally managed pharmaceutical company both in Philippines and in India under the name of Lloyd Laboratories, Private Limited. The company undertakes manufacturing Tablets, Capsules, Liquid Orals, Ointments, Injectables, Soft- Gelatin Capsules, Pellets, Metered-Dose Inhalers, Dry Powder Inhalers and Nasal Spray formulations with cGMP norms.
With constant innovation, advanced technologies and state-of-the-art manufacturing plants, Lloyd Laboratories, Inc. has, over the years, grown to be a name to reckon within the pharmaceuticals industry. The company has its manufacturing facility in Bulacan and Quezon City in the Philippines and Chennai, Aurungabad, Ahmedabad, Mumbai, in India and has over 500,000 square feet of built up area.
Lloyd Laboratories, Inc.’s product portfolio includes:
– Tablets, Capsules, Liquid Orals, Ointments, Injectables, Soft- Gelatin Capsules, Metered-Dose Inhalers, Dry Powder Inhalers and Nasal Sprays
– Products manufactured under most of the Specialized Therapeutic categories, such as Anti-infectives, Antidiabetics, Antihypertensives and Cardiology, Antiulcer, Anti-asthma, Anti-pain, Anti-Tuberculosis, Anti-psychotics, Pediatrics, Food and Nutritionals & Topical applications
– Improved drug delivery systems like sustained release, instant release, bi-layered tablet, tablet in tablet, mouth dissolving tablet, tablet in capsules, pellet technology, taste masking technology etc.
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
The election of maverick former mayor of Davao, Rodrigo Duterte to the Filipino presidency in May 2016 represented a dramatic departure from politics as usual and raised interesting questions about…
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into…
Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities.…
Cheryl Maley, General Manager of Novartis Philippines, discusses the company’s operations in the country, their growing portfolio of products as well as their impressive focus on research and development in…
Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that…
Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country. He also expands on the…
Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based…
See our Cookie Privacy Policy Here
